Answer
It increases venous and arterial blood-clot risk compared with non-use, although the overall risk remains small. Personal risk factors require assessment.
Sources for this answer
- Brevinor Tablets — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.